Tradestie Institutional Equity Comparison Engine
RGNX vs XNCR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XNCR Overall Edge
XNCR Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus XNCR at 68.0x Forward P/E and -72.7% operating margin (+454.9% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
XNCR
RGNX N/M vs XNCR 68.0x Fwd P/E
Growth & Margin Winner
XNCR
Op Margin -120.4% vs -72.7% ยท YoY -69.2% vs +454.9%
Momentum & Technical Winner
XNCR
1Y -35.8% vs +154.6% ยท 52W Pos 19% vs 84%
Options & Structure Winner
XNCR
BREAKDOWN (52nd %ile IV) vs BREAKOUT (10th %ile IV)
RGNX
NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap
$500.9M
1M Return
+7.87%
1Y Return
-35.82%
Forward P/E
N/M
Unified AI Score
45.3 / 100
HOLD
Tech 36.0
Fund 44.0
Flow 69.0
Mom 50.0
XNCR
NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.62
-3.98% 1D
Market Cap
$2.9B
1M Return
+55.86%
1Y Return
+154.57%
Forward P/E
68.0x
Unified AI Score
29.6 / 100
SELL
Tech 50.0
Fund 32.0
Flow 66.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RGNX -35.82%
XNCR +154.57%
Spread: +190.39 pp (XNCR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RGNX Revenue | XNCR Revenue | RGNX Op. Margin | XNCR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $220M | $40M | 40.3% | -195.5% | RGNX |
| FY2019 | $40M | $160M | -422.9% | 8.8% | XNCR |
| FY2020 | $150M | $120M | -77.1% | -62.6% | XNCR |
| FY2021 | $470M | $280M | 34.0% | 15.9% | RGNX |
| FY2022 | $110M | $160M | -233.2% | -50.1% | XNCR |
| FY2023 | $90M | $170M | -297.1% | -75.8% | XNCR |
| FY2024 | $80M | $110M | -280.0% | -161.5% | XNCR |
| FY2025 | $170M | $130M | -94.6% | -141.4% | RGNX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RGNX | XNCR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $500.9M | $2.9B | Larger Scale | XNCR |
| Trailing P/E Ratio Valuation | N/M | 68.0x | Lower Multiple | XNCR |
| Forward P/E Ratio Valuation | N/M | 68.0x | Lower Multiple | XNCR |
| Revenue Growth (YoY) Growth | -69.2% | +454.9% | Higher Growth | XNCR |
| Operating Margin (TTM) Profitability | -120.4% | -72.7% | Higher Margin | XNCR |
| Net Profit Margin Profitability | -113.9% | -58.8% | Higher Margin | XNCR |
| Return on Equity (ROE) Capital Efficiency | -113.2% | -19.9% | Higher ROE | XNCR |
| 52-Week Range Position Momentum | 19% ($5โ$16) | 84% ($10โ$41) | Stronger Trend | XNCR |
| Beta / 30D Volatility Risk Regime | 1.81ฮฒ ยท 76% Vol | 1.19ฮฒ ยท 86% Vol | Lower Realized Risk | RGNX |
| Unified Institutional Score Composite Signal | 45.3 / 100 (HOLD) | 29.6 / 100 (SELL) | Higher Composite | RGNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RGNX vs XNCR Buy Guide
RGNX
BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
52nd %ile
IV Regime
Balanced (25thโ60th %ile)
XNCR
BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RGNX nor XNCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.